"Advanced" Parkinson's disease: A review

被引:0
|
作者
Aslam, Sana [1 ]
Manfredsson, Fredric [1 ]
Stokes, Ashley [1 ]
Shill, Holly [1 ]
机构
[1] Barrow Neurol Inst, Phoenix, AZ USA
关键词
LEVODOPA-INDUCED DYSKINESIAS; SLEEP BEHAVIOR DISORDER; ALPHA-SYNUCLEIN; VISUAL HALLUCINATIONS; COGNITIVE IMPAIRMENT; NEURONAL LOSS; LEWY BODIES; GRAY-MATTER; RAT MODEL; DEMENTIA;
D O I
10.1016/j.parkreldis.2024.106065
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is no consensus driven definition of "advanced" Parkinson's disease (APD) currently. APD has been described in terms of emergence of specific clinical features and clinical milestones of the disease e.g., motor fluctuations, time to increasing falls, emergence of cognitive decline, etc. The pathological burden of disease has been used to characterize various stages of the disease. Imaging markers have been associated with various motor and nonmotor symptoms of advancing disease. In this review, we present an overview of clinical, pathologic, and imaging markers of APD. We also propose a model of disease definition involving longitudinal assessments of these markers as well as quality of life metrics to better understand and predict disease progression in those with Parkinson's disease.
引用
收藏
页数:9
相关论文
共 50 条